Cite
HARVARD Citation
Weinstock, M. et al. (2022). Complete responses to odronextamab in two patients with diffuse large B‐cell lymphoma refractory to chimeric antigen receptor T‐cell therapy. British journal of haematology. pp. 366-370. [Online].